Hatch-Waxman Improvement Act of 2022

Senate Bill 4378 - Hatch-Waxman Improvement Act of 2022: Overview, Status, and Impact

Hozzl · 2022-12-29T17:33:52Z

Explore the details of Senate Bill 4378 Hatch-Waxman Improvement Act of 2022 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/29/2022, 5:33 PM

Congressional Summary of S 4378

Hatch-Waxman Improvement Act of 2022

This bill extends through FY2026 provisions that establish a period of market exclusivity for certain new drugs with single enantiomers (i.e., one of a pair of molecules that are mirror images of one another).

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 4378

Bill S 4378 is currently in the status of Bill Introduced since June 13, 2022. Bill S 4378 was introduced during Congress 117 and was introduced to the Senate on June 13, 2022. Bill S 4378's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of June 13, 2022